Editorial Comments on "The safety, tolerability, and efficacy of once-daily generic memantine hydrochloride produced in Thailand: A multicenter naturalistic study in dementia patients"

Main Article Content

Orapitchaya Krairit

Abstract

Dementia is a syndrome decline in 2 or more cognitive capacities, causing impairment in function. One of the risk factors for dementia is advanced age. Dementia has become increasingly more common in Thai older adults given the sharp rising number of older people in Thailand. Current available pharmacological treatment aims for delaying progression of the syndrome and to treat the symptoms of dementia are Cholinesterase inhibitors and Memantine. Using generic medication will decrease the price of overall pharmacological treatment.

Keywords

Article Details

How to Cite
Krairit, O. (2015). Editorial Comments on "The safety, tolerability, and efficacy of once-daily generic memantine hydrochloride produced in Thailand: A multicenter naturalistic study in dementia patients". Ramathibodi Medical Journal, 38(1), 1-2. Retrieved from https://www.tci-thaijo.org/index.php/ramajournal/article/view/95131
Section
Editor's Note

References

1. Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorder: the DSM-5 approach. Nature Reviews Neurology. 2014;10:634-42.

2. Rabins PV, Blass DM. In the Clinic. Dementia. Annals of Internal Medicine. 2014;161:ITC1; quiz ITC16.

3. Australia AsDIAs. Dementia in the Asia Pacific Region: Alzheimer’s Disease International, London; 2014.

4. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. Effectiveness of cholinesterase inhibitions and memantine for treating dementia: evidence review for a clinical practice guideline. Annals of Internal Medicine. 2008;148:379-97.